Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
The medical device sector is considered as one of the sunrise sectors in the country
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
This transformation will enable GE HealthCare to build a strong foundation for business growth
Collaboration to provide hospitals with a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
Urges Innovators to produce quality products that can be deployed at scale
Subscribe To Our Newsletter & Stay Updated
